He added that the discovery helps provide a new direction for researchers to design drugs that target the good places and not the bad places. With Oxytocin, a GLP-1 Agonist Caused More Weight Loss with No Gastrointestinal Side Effects Oxytocin, colloquially called the love hormone, is best known for its associations with feelings of trust and attachment
For women with PCOS, GLP-1 receptor agonists have shown better outcomes compared to metformin, particularly in weight loss and improving insulin resistance
Oral GLP-1 receptor agonists are also in the development phase, with preliminary data showing efficacy similar to that of Semaglutide
1a, Supplementary Table 1)
However, the Look AHEAD trial and other studies examining intentional weight loss and cognition have shown variable results, suggesting this relationship is not straightforward
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database